Therapeutic drug monitoring of mycophenolic acid in patients with kidney transplant
Zvonimir Puretić, Paula Granić, Ljubica Bubić-Filipi, Zdenka Lalić, Mila Lovrić, Ines Humar, Željka Mustapić, Jadranka Sertić, Kes P
Abstract
Zvonimir Puretić, Paula Granić, Ljubica Bubić-Filipi, Zdenka Lalić, Mila Lovrić, Ines Humar, Željka Mustapić, Jadranka Sertić, Kes P
Abstract
Mycophenolate mofetil (MMF) is an immunosupressive drug used in prophylaxis of rejection of transplanted solid organs in combination with cyclosporine A (CyA) and steroids. It is metabolised in the liver to the active component mycophenolic acid (MPA), an irreversible noncompetitive inhibitor of cell enzime 5'-monophosphate (IMP)dehydrogenase. The aim of the study was...
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Mycophenolate mofetil (MMF) is an immunosupressive drug used in prophylaxis of rejection of transplanted solid organs in combination with cyclosporine A (CyA) and steroids. It is metabolised in the liver to the active component mycophenolic acid (MPA), an irreversible noncompetitive inhibitor of cell enzime 5'-monophosphate (IMP)dehydrogenase. The aim of the study was...
Key concepts: Mycophenolic acid, Mycophenolate, Pharmacology, Drug, Therapeutic drug monitoring, Immunosuppressive drug, IMP dehydrogenase, Medicine